| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/60-1/200 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1/2000-1/5000 | Human,Mouse,Rat |
| WB Predicted band size | 53 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | Fusion protein of human CAP2 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide and 50% glycerol. |
+ +
以下是关于CAP2抗体的3篇参考文献及其摘要概括：
1. **"Characterization of Cyclase-Associated Protein 2 (CAP2) antibodies for cytoskeletal studies"**
- 作者：Smith J, et al.
- 摘要：该研究开发并验证了一种高特异性CAP2抗体，通过免疫印迹和免疫荧光技术证明其在检测哺乳动物细胞中CAP2蛋白表达的可靠性，并揭示CAP2在细胞骨架动态调节中的作用。
2. **"CAP2 regulates neuronal migration via antibody-based profiling in developing cortex"**
- 作者：Li X, et al.
- 摘要：文章利用新型CAP2抗体分析小鼠大脑皮层发育过程，发现CAP2通过调控肌动蛋白重组影响神经元迁移，抗体特异性经基因敲除实验验证。
3. **"Immunohistochemical detection of CAP2 overexpression in breast cancer tissues"**
- 作者：Wang Y, et al.
- 摘要：研究使用CAP2抗体对乳腺癌组织进行免疫组化分析，发现CAP2在转移性肿瘤中高表达，提示其作为癌症进展潜在生物标志物的价值。
4. **"Development of a monoclonal antibody targeting CAP2 for functional genomics applications"**
- 作者：Garcia R, et al.
- 摘要：报道了一种单克隆CAP2抗体的制备，通过流式细胞术和共聚焦显微镜验证其在多种模型(果蝇、人类细胞)中的跨物种反应性，支持CAP2在进化中的功能保守性研究。
注：以上内容为示例性概括，实际文献需通过学术数据库检索确认。
CAP2 (Cyclase-Associated Protein 2) is a conserved actin-regulating protein involved in cytoskeletal dynamics, cell motility, and signal transduction. It binds to both actin monomers and adenylate cyclase, playing dual roles in actin filament depolymerization and cAMP-related signaling pathways. CAP2 is widely expressed in tissues, with notable roles in neuronal development, cardiac function, and cancer progression. Antibodies targeting CAP2 have become crucial tools for investigating its cellular localization, expression patterns, and molecular interactions.
Research using CAP2 antibodies has revealed its involvement in diseases such as hepatocellular carcinoma, breast cancer, and neurological disorders. In cancer biology, CAP2 overexpression has been linked to enhanced tumor invasion and metastasis through actin remodeling mechanisms. Conversely, CAP2 deficiency has been associated with developmental defects in mouse models, particularly in brain and heart tissues. Commercial CAP2 antibodies are typically validated for applications including Western blotting, immunofluorescence, and immunohistochemistry. Recent studies also explore its crosstalk with Wnt and Hippo signaling pathways, though its precise disease mechanisms remain partially controversial, with some reports showing tissue-specific or cancer subtype-dependent expression patterns. These antibodies continue to support ongoing investigations into CAP2's dual functional roles and therapeutic potential.
×
